Elizabeth Gough-Gordon, Digital Content Editor

Imprimis Pharmaceuticals announced that it has made available a compounded formulation of pyrimethamine and leucovorin.

The Centers for Disease Control and Prevention (CDC) has launched an updated Foodborne Outbreak Online Database Tool (FOOD Tool) to assist users in searching over nearly 20 years of outbreak data.

Pregnant women taking antiviral medications to treat hepatitis C and/or HIV with non-steroidal anti-inflammatories (NSAIDs) or antihypertensives may have an increased risk of birth defects or stunted fetal growth, although these antiviral drugs have not been shown to directly cause harm to a fetus.

The Food and Drug Administration (FDA) has ordered the three manufacturers of duodenoscopes marketed in the United States to conduct postmarket surveillance studies for greater understanding of how the devices are reprocessed in real-world settings.

The American College of Chest Physicians has issued an evidence-based guideline on appropriate treatments for unexplained chronic cough (UCC), including pharmacotherapy and speech pathology.

The newly expanded codes in ICD-10 will grant healthcare professionals greater specificity and clinical accuracy for noting procedures and diagnoses, but could also present obstacles and headaches in the transition from the previous ICD-9 codes.

Turing Pharmaceuticals has agreed to reduce the cost of its drug Daraprim (pyrimethamine) after receiving significant criticism due to a sudden increase in the price of the medication.

Prompt antiviral therapy can reduce the need for extended care among community-dwelling patients aged ≥65 in this first-of-its-kind research.

One of the first and largest published studies of PrEP in a clinical setting found no new cases of HIV among patients after initiation of PrEP.

Even with vaccination, children with HIV may not have sufficient immunity against measles, mumps, and rubella.